Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v6-EN
Language French English
Date Updated 2020-04-02 2020-04-01
Drug Identification Number 02390051 02390051
Brand name ONDANSETRON INJECTION, USP ONDANSETRON INJECTION, USP
Common or Proper name ONDANSETRON INJECTION, USP ONDANSETRON INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ONDANSETRON ONDANSETRON
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20ML 1VL 20ML 1VL
ATC code A04AA A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2020-03-31 2020-03-31
Actual start date
Estimated end date 2020-05-12 2020-05-12
Actual end date 2020-04-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments